Johnson & Johnson (NYSE: JNJ) Seen Running Too Hot, Let’s Look At This More Closely
Capital Research & Management Co recently announced the acquisition of new stake in Johnson & Johnson (NYSE:JNJ). The institutional investor has increased its shareholding in the Healthcare company by 4.17% to 28.99 million shares with purchase of 1.16 million shares. This fresh investment now brings its stake to 1.20% valued currently at $4.48 billion. In […]
